Cited by 47Metabolism, Diabetes, and CancerNatural Antidiabetic Agents StudiesAdipose Tissue and Metabolism

Potentiation of insulin-stimulated glucose transport by the AMP-activated protein kinase

Open access
Ju, Jeong-Sun, Gitcho, Michael A., Casmaer, Carter A., Patil, Pankaj B., Han, Dae-Gyue, Spencer, Susan A., Fisher, Jonathan S.·2007·American Journal of Physiology-Cell Physiology

Abstract

Data from the use of activators and inhibitors of the AMP-activated protein kinase (AMPK) suggest that AMPK increases sensitivity of glucose transport to stimulation by insulin in muscle cells. We assayed insulin action after adenoviral (Ad) transduction of constitutively active (CA; a truncated form of AMPKα 1) and dominant-negative (DN; which depletes endogenous AMPKα) forms of AMPKα (Ad-AMPKα-CA and Ad-AMPKα-DN, respectively) into C 2 C 12 myotubes. Compared with control (Ad-green fluorescent protein), Ad-AMPK-CA increased the ability of insulin to stimulate glucose transport. The increased insulin action in cells expressing AMPK-CA was suppressed by compound C (an AMPK inhibitor). Exposure of cells to 5-aminoimidazole-4-carboxamide-1β-d-ribofuranoside (an AMPK activator) increased insulin action in uninfected myotubes and myotubes transduced with green fluorescent protein but not in Ad-AMPK-DN-infected myotubes. In Ad-AMPK-CA-transduced cells, serine phosphorylation of insulin receptor substrate 1 was decreased at a mammalian target of rapamycin (or p70 S6 kinase) target site that has been reported to be associated with insulin resistance. These data suggest that, in myotubes, activated AMPKα 1 is sufficient to increase insulin action and that the presence of functional AMPKα is required for 5-aminoimidazole-4-carboxamide-1β,d-ribofuranoside-related increases in insulin action.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1152/ajpcell.00269.2006

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Incubation with AICAR in C2C12 myotubes transfected with constitutively active or KD AMPKα revealed that serine phosphorylation of IRS1 was decreased at a target site of mTOR/p70 S6K.

    “Similarly, incubation with AICAR in C2C12 myotubes transfected with an adenovirus of a constitutively active (truncated form of AMPKα1) or KD form of AMPKα revealed that serine phosphorylation of IRS1 was decreased at a target site of mTOR/p70 S6K, which has been associated with insulin resistance [158].”

    From AMPK and Exercise: Glucose Uptake and Insulin Sensitivity (2013) · cites this paper as [158]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 44 · Cited by 47

Authors
Ju, J.-S., Gitcho, M. A., Casmaer, C. A., Patil, P. B., Han, D.-G., Spencer, S. A., & Fisher, J. S.
Affiliations
Saint Louis University (US)
Venue
American Journal of Physiology-Cell Physiology
Published
2007-01
Volume
292
Issue
1
Pages
C564-C572
ISSN
  • 0363-6143 (ISSN-L)
  • 1522-1563
OpenAlex
W2107627105
Cited by
47
References
44
Citations by year
2026: 1 · 2020: 5 · 2019: 1 · 2018: 1 · 2016: 1 · 2015: 1 · 2014: 5 · 2013: 3 · 2012: 5
FWCI
2.18
Type
journal article
Language
en
Open access
Locations
  • American Journal of Physiology-Cell Physiology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • University of Pennsylvania
  • National Institute of Diabetes and Digestive and Kidney Diseases (K01DK066330)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
Keywords
AMPK, insulin-stimulated glucose transport, insulin sensitivity, muscle cells, C2C12 myotubes, AMPKα1, compound C, IRS-1, serine phosphorylation, mTOR, p70 S6 kinase, insulin resistance, adenoviral transduction
MeSH terms
Aminoimidazole Carboxamide, Animals, Biological Transport, Cells, Cultured, Drug Synergism, Genes, Dominant, Glucose, Hypoglycemic Agents, Insulin, Isoenzymes, Multienzyme Complexes, Phosphoproteins, Phosphorylation, Protein Kinases, Ribonucleotides, Signal Transduction, Protein Serine-Threonine Kinases, Muscle Fibers, Skeletal, Enzyme Activators, Luminescent Agents, Green Fluorescent Proteins, Mice, AMP-Activated Protein Kinases, Insulin Receptor Substrate Proteins, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review